Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Silvia Lupi, Armando Stefanati, Tatjana Baldovin, Alberto Roman, Vincenzo Baldo & Giovanni Gabutti. (2019) Assessment of seroprevalence against poliovirus among Italian adolescents and adults. Human Vaccines & Immunotherapeutics 15:3, pages 677-682.
Read now
Read now
Giovanni M. Giammanco, Angela Bechini, Noemi Urone, Floriana Bonura, Sara Li Muli, Simona De Grazia, Irene Bellini, Emilia Tiscione, Sara Boccalini & Antonino Nastasi. (2018) Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy. Human Vaccines & Immunotherapeutics 14:9, pages 2248-2253.
Read now
Read now
Articles from other publishers (5)
Jean Harb, Nicolas Mennesson, Cassandra Lepetit, Maeva Fourny, Margaux Louvois, Adrien Bosseboeuf, Sophie Allain-Maillet, Olivier Decaux, Caroline Moreau, Anne Tallet, Eric Piver, Philippe Moreau, Valéry Salle, Edith Bigot-Corbel & Sylvie Hermouet. (2021) Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens. Cells 10:2, pages 438.
Crossref
Crossref
Alexandra J. Hendry, Frank H. Beard, Aditi Dey, Helen Quinn, Linda Hueston, Dominic E. Dwyer & Peter B. McIntyre. (2020) Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine. Vaccine 38:11, pages 2572-2577.
Crossref
Crossref
Paola Anello, Laura Cestari, Tatjana Baldovin, Lorenzo Simonato, Gabriella Frasca, Nicola Caranci, Maria Grazia Pascucci, Francesca Valent & Cristina Canova. (2017) Socioeconomic factors influencing childhood vaccination in two northern Italian regions. Vaccine 35:36, pages 4673-4680.
Crossref
Crossref
H.F. Florindo, J. Lopes, L.C. Silva, M.L. Corvo, M.B. Martins & R. Gaspar. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
393
410
.
Felicity T. Cutts & Matt Hanson. (2016) Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low‐ and middle‐income countries. Tropical Medicine & International Health 21:9, pages 1086-1098.
Crossref
Crossref